Each new outbreak of Ebola is another chance to learn about the disease: How it begins, how it spreads, and how it continues to affect survivors long after the acute stage is over. Now, researchers have added another goal to epidemiological studies, tracking the efficacy of a new vaccine. WASHINGTONContinue Reading